Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Why Beyond Meat Stock Is Likely to Stumble Again

By InvestorPlace Research Staff
Beyond Meat stock is rolling again. But investors need to watch out for two key risks that could derail the stock in 2020.

With NVDA Stock Topping Out, It May Be Time to Sell

By Thomas Niel, InvestorPlace Contributor
Although NVDA stock has moved significantly higher from its lows, competitive risks and a rich premium should worry shareholders.

There Really Is Nothing to Prevent CHK Stock from Trending Lower

By Todd Shriber, InvestorPlace Contributor
Shares of the natural gas producer experienced a nice rally in December, but that wasn't nearly enough to shake Chesapeake stock out of what had become a lengthy slumber. Moreover, the coronavirus outbreak has crippled energy commodities in the early innings of 2020, but even if that wasn't an issue to contend with, Chesapeake has headline risk of its own to contend with.

Time Is Running Out for AMD Stock

By Ian Bezek, InvestorPlace Contributor
AMD just reported its earnings, and once again, its results and guidance were fairly soft. As such, it's a good time to ring the register on AMD stock.

When I’d Be Looking to Sell Tesla Stock

By Louis Navellier, Editor, Growth Investor
According to the talking media heads, everything is going perfectly for Tesla stock. However, they are leaving out a few key details that show otherwise.

Why Johnson & Johnson Is Deceptively Boring

By Luke Lango, InvestorPlace Senior Investment Analyst
JNJ stock is on a scorching run in the markets recently, but the underlying fundamentals suggest that shares are close to fully pricing in the optimism.

Is BIDU Stock Merely Sick or Is It Something Worse?

By Chris Markoch, InvestorPlace Contributor
BIDU stock might tempt some investors due to its recent discount but the ambiguity over the seriousness of the coronavirus clouds the narrative.

The Bizarre Run in Nio Stock Is Over: Get Out Now

By Ian Bezek, InvestorPlace Contributor
Nio stock shot back up in recent weeks. But there's little fundamental basis for the rally, and coronavirus could hit the company hard.

Even After a Dismal 2019, FCEL Stock Is Still Overvalued

By Larry Ramer, InvestorPlace Contributor
Weak demand for FuelCell's power, poor financial results and a high valuation should cause FCEL stock to drop further.

Tesla Stock Investors Need to Keep It Real

By Wayne Duggan, InvestorPlace Contributor
Tesla reported another solid quarter last week. But even Tesla stock bulls must admit the shares are at least temporarily caught in a market mania.

3 Reasons Investors Should Be Skeptical of Lyft’s 2020 Rally

By Marie Brodbeck, InvestorPlace Contributor
A tougher regulatory environment, a fast changing industry and impossible growth projections make Lyft stock a risky play right now.

High-Tech Disruptors Are Coming to Sink Old-School Rite Aid

By InvestorPlace Research Staff
RAD stock jumped higher off a strong Q4 earnings beat but without a viable recovery narrative. This is where the story ends.

Rite Aid Stock: Risk Lovers, Speculators Inquire Within

By Todd Shriber, InvestorPlace Contributor
There's an old investment saying that goes something like (forgive my paraphrasing) “credit leads equity.” What that means is that a company's corporate debt can be a tell about future price action in the stock. Rite Aid recently exchanged $600 million in notes coming due in 2023 for notes maturing in 2025. While that move will help with interest expense, at least one ratings agency doesn't see a reason to upgrade the company's flimsy credit rating.

Canopy Growth Stock Remains Unattractive For 2020 Off High Cash Burn

By Faisal Humayun, InvestorPlace Contributor
Slow growth across the medicinal cannabis sector and a high rate of cash burn are major concerns for Canopy Growth and equity dilution seems likely in 2020.

Sensible Investors Will Ditch Acasti Pharma for Amarin 

By Will Ashworth, InvestorPlace Contributor
Acasti Pharma lost $118 million in market capitalization on January 13. That makes Acasti Pharma stock a liability, not a bargain.

Traders Can Make Money on PIR Stock, but Investors Should Steer Clear

By Larry Ramer, InvestorPlace Contributor
Pier 1 doesn't have what it takes to be a winner, and the company's results will continue to deteriorate, so investors should avoid PIR stock.

FCEL Stock Needs More Than One Catalyst

By Chris Markoch, InvestorPlace Contributor
Initially, FCEL stock compels due to the underlying alternative energy business. However, this segment is also rather niche and features heavy competition.

Nokia Stock Is a 5G Cup of Coffee That Risks Burning Investors

By Todd Shriber, InvestorPlace Contributor
The 5G rollout is happening this year, but that doesn't mean NOK stock is a buy; Not with Nokia's recent history of disappointment.

For Potential GE Stock Investors, This Turnaround is Too Little, Too Late

By Patrick Sanders, InvestorPlace Contributor
General Electric was once one of the best companies on Wall Street, but its time has come and gone. There are better options out there than GE stock.
Load More Articles